These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 23116442

  • 1. Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies.
    Domingues MM, Santos NC, Castanho MA.
    Curr Protein Pept Sci; 2012 Nov; 13(7):611-9. PubMed ID: 23116442
    [Abstract] [Full Text] [Related]

  • 2. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 3. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures.
    Domingues MM, Bianconi ML, Barbosa LR, Santiago PS, Tabak M, Castanho MA, Itri R, Santos NC.
    Biochim Biophys Acta; 2013 Nov 15; 1828(11):2419-27. PubMed ID: 23792068
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
    Wiese A, Brandenburg K, Carroll SF, Rietschel ET, Seydel U.
    Biochemistry; 1997 Aug 19; 36(33):10311-9. PubMed ID: 9254630
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria.
    Domingues MM, Silva PM, Franquelim HG, Carvalho FA, Castanho MA, Santos NC.
    Nanomedicine; 2014 Apr 19; 10(3):543-51. PubMed ID: 24262996
    [Abstract] [Full Text] [Related]

  • 6. rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes.
    Domingues MM, Castanho MA, Santos NC.
    PLoS One; 2009 Dec 22; 4(12):e8385. PubMed ID: 20027298
    [Abstract] [Full Text] [Related]

  • 7. Molecular mechanisms of membrane targeting antibiotics.
    Epand RM, Walker C, Epand RF, Magarvey NA.
    Biochim Biophys Acta; 2016 May 22; 1858(5):980-7. PubMed ID: 26514603
    [Abstract] [Full Text] [Related]

  • 8. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.
    Chen X, Dings RP, Nesmelova I, Debbert S, Haseman JR, Maxwell J, Hoye TR, Mayo KH.
    J Med Chem; 2006 Dec 28; 49(26):7754-65. PubMed ID: 17181157
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
    Zhang LT, Yao YM, Lu JQ, Yan XJ, Yu Y, Sheng ZY.
    Shock; 2008 Feb 28; 29(2):278-84. PubMed ID: 17693935
    [Abstract] [Full Text] [Related]

  • 11. De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs.
    Bhattacharjya S.
    Curr Med Chem; 2010 Feb 28; 17(27):3080-93. PubMed ID: 20629624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
    Marra MN, Thornton MB, Snable JL, Leong S, Lane J, Wilde CG, Scott RW.
    Blood Purif; 1993 Feb 28; 11(2):134-40. PubMed ID: 7506040
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic potential of the bactericidal/permeability-increasing protein.
    Levy O.
    Expert Opin Investig Drugs; 2002 Feb 28; 11(2):159-67. PubMed ID: 11829710
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
    Levy O, Sisson RB, Kenyon J, Eichenwald E, Macone AB, Goldmann D.
    Infect Immun; 2000 Sep 28; 68(9):5120-5. PubMed ID: 10948134
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.